Strain Data Sheet

RBRC00906

Strain Information

Image
BRC No.RBRC00906
TypeTransgeneCartagena
SpeciesMus musculus
Strain nameC57BL/6-Tg(pLck-EGFP)1Naka/Rbrc
Former Common nameplck-GFP Tg
H-2 Haplotype
ES Cell line
Background strainC57BL/6JJcl
Appearanceblack [(a/a B/B C/C)]
Strain developmentDeveloped by Dr. Toshinori Nakayama, Graduate School of Medicine, Chiba University in 2001. The 4.2 kb pLck-EGFP plasmid was purified and injected into the pronucleous of C57BL/6J fertilized eggs. Transgenic mice were backcrossed to C57BL/6 for 4 times.
Strain descriptionC57BL/6-Tg(pLck-EGFP)1Naka. The plck-GFP transgenic mice carry EGFP (enhanced green fluorescence protein) cDNA under control of the proximal promoter of Lck (lymphocyte protein tryosine kinase). The Lck proximal promoter is reported to be most active in immature thymocytes. These transgenic mice are powerful tools for the visualization of the intracellular machinery that is crucial for the development of lymphocytes.
Colony maintenanceBackcross to C57BL/6J (Hemizygote x C57BL/6JJcl).Reproductive performance is good.
References
Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity.
Shimizu C, Kawamoto H, Yamashita M, Kimura M, Kondou E, Kaneko Y, Okada S, Tokuhisa T, Yokoyama M, Taniguchi M, Katsura Y, Nakayama T
Int. Immunol., 13, 105-117 (2001). 11133839

Health Report

Examination Date / Room / Rack

Gene

Gene SymbolGene NameChr.Allele SymbolAllele NameCommon NamesPromoterDiseases Related to This Gene
GFP Green Fluorescent Protein (Aequorea victoria)UN lck proximal promoter, human growth hormone enhancer
GH Growth hormone polyA (human)UNGH

Phenotype

Annotation by Mammalian phenotyhpe ontology
  • obsolete no phenotypic analysis(MP:0003012)
  • Detailed phenotype data

    Ordering Information

    Donor DNAproximal lck promoter, Jellyfish GFP cDNA, human GH enhancer
    Research applicationFluorescent Proteins/lacZ System
    Immunology and Inflammation Research
    Specific Term and ConditionsThe RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Int. Immunol., 13(1) 105-117 (2001). The RECIPIENT agrees to include the DEPOSITOR/DEVELOPER as a co-author in any publications resulted by the use of the BIOLOGICAL RESOURCE during the first 2 years after deposition by the DEPOSITOR to the RIKEN BRC.
    The RECIPIENT should contact the DEPOSITOR in the case of application for any patents or commercial use with the results from the use of the BIOLOGICAL RESOURCE.
    DepositorToshinori Nakayama (Chiba University)
    Strain Statusan icon for Frozen embryosFrozen embryos
    Strain AvailabilityRecovered litters from cryopreserved embryos (2 to 4 months)
    Cryopreserved embryos (within 1 month)
    Additional Info.Necessary documents for ordering:
    1. Approval form (Japanese / English)
    2. Order form (Japanese / English)
    3. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
    4. Acceptance of responsibility for living modified organism (Japanese / English)
    Lab HP
    Genotyping protocol -PCR-

    BRC mice in Publications

    No Data